Integrating Artificial Intelligence and Digital Innovations in Psychedelic and Brain Therapeutics.
ACS Medicinal Chemistry Letters January 23, 2025 DOI: 10.1021/acsmedchemlett.5c00029 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Commentary Peer reviewed |
|---|---|
| Key points | Argues that three patented technologies—deuterated empathogens for psychiatric treatment, AI-powered digital platforms for cognitive and immune enhancement, and AI/ML performance-monitoring frameworks for wireless systems—together represent a paradigm shift, with molecular and digital advances converging to address mental health, neurodegenerative disease, and communication challenges. |
Abstract
The intersection of artificial intelligence (AI), digital therapeutics, and advanced communication frameworks offers transformative opportunities for addressing mental health disorders, neurodegenerative diseases, and communication challenges in modern networks. This Patent Highlight examines three pivotal patents that introduce deuterated empathogens for safer psychiatric treatments, AI-powered digital platforms for cognitive and immune function enhancement, and robust frameworks for AI/ML performance monitoring in wireless systems. Together, these innovations represent a paradigm shift in therapeutic and technological approaches, emphasizing the synergy of molecular and digital advancements in tackling global health and communication challenges.
Citations in the library
Cites 6
- Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them - A scoping review of available literature. Brain Research 2025
- MDMA-assisted psychotherapy for the treatment of PTSD: A systematic review and meta-analysis of randomized controlled trials (RCTs). Neuropsychopharmacology Reports December 1, 2024
- Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology. Translational Psychiatry December 4, 2024
- Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review. Mol Med December 19, 2024
- Harnessing Pharmacogenomics in Clinical Research on Psychedelic‐Assisted Therapy Clinical Pharmacology & Therapeutics September 30, 2024
and 1 more in the library